A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features
- 1 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 90 (1077) , 20170269
Abstract
Objective: To assess whether a computer-aided, diagnosis (CAD) system can predict pathological Complete Response (pCR) to neoadjuvant chemotherapy (NAC) prior to treatment using texture features. Methods: Response to treatment of 44 patients was defined according to the histopatology of resected tumour and extracted axillary nodes in two ways: (a) pCR+ (Smith’s Grade = 5) vs pCR− (Smith’s Grade < 5); (b) pCRN+ (pCR+ and absence of residual lymph node metastases) vs pCRN−. A CAD system was developed to: (i) segment the breasts; (ii) register the DCE-MRI sequence; (iii) detect the lesion and (iv) extract 27 3D texture features. The role of individual texture features, multiparametric models and Bayesian classifiers in predicting patients’ response to NAC were evaluated. Results: A cross-validated Bayesian classifier fed with 6 features was able to predict pCR with a specificity of 72% and a sensitivity of 67%. Conversely, 2 features were used by the Bayesian classifier to predict pCRN, obtaining a sensitivity of 69% and a specificity of 61%. Conclusion: A CAD scheme, that extracts texture features from an automatically segmented 3D mask of the tumour, could predict pathological response to NAC. Additional research should be performed to validate these promising results on a larger cohort of patients and using different classification strategies. Advances in knowledge: This is the first study assessing the role of an automatic CAD system in predicting the pathological response to NAC before treatment. Fully automatic methods represent the backbone of standardized analysis and may help in timely managing patients candidate to NAC.Keywords
This publication has 52 references indexed in Scilit:
- Performance of a fully automatic lesion detection system for breast DCE‐MRIJournal of Magnetic Resonance Imaging, 2011
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based ChemotherapyJournal of Clinical Oncology, 2011
- Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer SubtypeJournal of Clinical Oncology, 2011
- Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imagingEuropean Radiology, 2010
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working groupEuropean Journal of Cancer, 2010
- Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breastBreast Cancer Research, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and RecommendationsJournal of Clinical Oncology, 2003
- MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast CancerAnnals of Surgical Oncology, 2001
- Correlation between Steroid Hormone Receptors and Prognostic Factors in Human Breast CancerOncology, 1987